Global Nuclear Medicine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Nuclear Medicine market size will reach 8,032.89 Million USD in 2025 and is projected to reach 13,353.02 Million USD by 2032, with a CAGR of 7.53% (2025-2032). Notably, the China Nuclear Medicine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Nuclear medicine is a medical specialty that utilizes small amounts of radioactive substances, known as radiopharmaceuticals, to diagnose, treat, and monitor diseases. It combines molecular biology, nuclear physics, and medical imaging techniques to provide valuable information about the functioning and structure of organs and tissues in the body. In diagnostic nuclear medicine procedures, patients are administered radiopharmaceuticals either orally, by injection, or by inhalation. These substances emit gamma rays or positrons, which are then detected by specialized imaging devices such as gamma cameras or positron emission tomography (PET) scanners. The captured data is processed to create detailed images that highlight areas of abnormal function or metabolism. Nuclear medicine is particularly useful in the diagnosis and staging of various conditions, including cancer, heart disease, neurological disorders, and thyroid disorders. It also plays a role in therapeutic applications, such as targeted radiation therapy for certain cancers. Nuclear medicine techniques offer valuable insights into the physiological processes within the body, enabling physicians to make more accurate diagnoses, tailor treatment plans, and monitor treatment effectiveness.
The major global manufacturers of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Jubilant Pharma, Nordion, Eli Lilly, SIEMENS, China Isotope & Radiation, Dongcheng Pharmaceutical Group, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Nuclear Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nuclear Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Nuclear Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nuclear Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Nuclear Medicine Include:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Nuclear Medicine Product Segment Include:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Nuclear Medicine Product Application Include:
Diagnostic
Therapeutic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Nuclear Medicine Industry PESTEL Analysis
Chapter 3: Global Nuclear Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Nuclear Medicine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Nuclear Medicine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Nuclear Medicine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Nuclear Medicine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Nuclear Medicine market size will reach 8,032.89 Million USD in 2025 and is projected to reach 13,353.02 Million USD by 2032, with a CAGR of 7.53% (2025-2032). Notably, the China Nuclear Medicine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Nuclear medicine is a medical specialty that utilizes small amounts of radioactive substances, known as radiopharmaceuticals, to diagnose, treat, and monitor diseases. It combines molecular biology, nuclear physics, and medical imaging techniques to provide valuable information about the functioning and structure of organs and tissues in the body. In diagnostic nuclear medicine procedures, patients are administered radiopharmaceuticals either orally, by injection, or by inhalation. These substances emit gamma rays or positrons, which are then detected by specialized imaging devices such as gamma cameras or positron emission tomography (PET) scanners. The captured data is processed to create detailed images that highlight areas of abnormal function or metabolism. Nuclear medicine is particularly useful in the diagnosis and staging of various conditions, including cancer, heart disease, neurological disorders, and thyroid disorders. It also plays a role in therapeutic applications, such as targeted radiation therapy for certain cancers. Nuclear medicine techniques offer valuable insights into the physiological processes within the body, enabling physicians to make more accurate diagnoses, tailor treatment plans, and monitor treatment effectiveness.
The major global manufacturers of Nuclear Medicine include GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Jubilant Pharma, Nordion, Eli Lilly, SIEMENS, China Isotope & Radiation, Dongcheng Pharmaceutical Group, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Nuclear Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nuclear Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Nuclear Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nuclear Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Nuclear Medicine Include:
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Jubilant Pharma
Nordion
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Nuclear Medicine Product Segment Include:
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Nuclear Medicine Product Application Include:
Diagnostic
Therapeutic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Nuclear Medicine Industry PESTEL Analysis
Chapter 3: Global Nuclear Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Nuclear Medicine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Nuclear Medicine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Nuclear Medicine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Nuclear Medicine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Nuclear Medicine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Nuclear Medicine Product by Type
- 1.2.1 Tc-99
- 1.2.2 I-123/131
- 1.2.3 In-111
- 1.2.4 Xe-133
- 1.2.5 Th-201
- 1.2.6 Ga-67
- 1.2.7 Others
- 1.3 Nuclear Medicine Product by Application
- 1.3.1 Diagnostic
- 1.3.2 Therapeutic
- 1.4 Global Nuclear Medicine Market Revenue and Sales Analysis
- 1.4.1 Global Nuclear Medicine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Nuclear Medicine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Nuclear Medicine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Nuclear Medicine Market Development Status and Trends
- 1.5.1 Nuclear Medicine Industry Development Status Analysis
- 1.5.2 Nuclear Medicine Industry Development Trends Analysis
- 2 Nuclear Medicine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Nuclear Medicine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Nuclear Medicine Market Analysis by Country
- 4.1 Global Nuclear Medicine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Nuclear Medicine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Nuclear Medicine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Nuclear Medicine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Nuclear Medicine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Nuclear Medicine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Nuclear Medicine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Nuclear Medicine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Nuclear Medicine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Nuclear Medicine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Nuclear Medicine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Nuclear Medicine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Nuclear Medicine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Nuclear Medicine Market Analysis by Type
- 6.1 Global Nuclear Medicine Market Revenue Analysis by Type
- 6.1.1 Global Nuclear Medicine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Nuclear Medicine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Nuclear Medicine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Nuclear Medicine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 GE Healthcare
- 7.1.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 GE Healthcare Nuclear Medicine Product Portfolio
- 7.1.3 GE Healthcare Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Bracco Imaging
- 7.2.1 Bracco Imaging Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Bracco Imaging Nuclear Medicine Product Portfolio
- 7.2.3 Bracco Imaging Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Mallinckrodt
- 7.3.1 Mallinckrodt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Mallinckrodt Nuclear Medicine Product Portfolio
- 7.3.3 Mallinckrodt Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Lantheus Medical Imaging
- 7.4.1 Lantheus Medical Imaging Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Lantheus Medical Imaging Nuclear Medicine Product Portfolio
- 7.4.3 Lantheus Medical Imaging Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Bayer
- 7.5.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Bayer Nuclear Medicine Product Portfolio
- 7.5.3 Bayer Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Triad Isotopes
- 7.6.1 Triad Isotopes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Triad Isotopes Nuclear Medicine Product Portfolio
- 7.6.3 Triad Isotopes Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Jubilant Pharma
- 7.7.1 Jubilant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Jubilant Pharma Nuclear Medicine Product Portfolio
- 7.7.3 Jubilant Pharma Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Nordion
- 7.8.1 Nordion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Nordion Nuclear Medicine Product Portfolio
- 7.8.3 Nordion Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Eli Lilly
- 7.9.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Eli Lilly Nuclear Medicine Product Portfolio
- 7.9.3 Eli Lilly Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 SIEMENS
- 7.10.1 SIEMENS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 SIEMENS Nuclear Medicine Product Portfolio
- 7.10.3 SIEMENS Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 China Isotope & Radiation
- 7.11.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 China Isotope & Radiation Nuclear Medicine Product Portfolio
- 7.11.3 China Isotope & Radiation Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Dongcheng Pharmaceutical Group
- 7.12.1 Dongcheng Pharmaceutical Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Dongcheng Pharmaceutical Group Nuclear Medicine Product Portfolio
- 7.12.3 Dongcheng Pharmaceutical Group Nuclear Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Nuclear Medicine Industry Chain Analysis
- 8.2 Nuclear Medicine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Nuclear Medicine Product Downstream Application Analysis
- 8.3.1 Global Nuclear Medicine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Nuclear Medicine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Nuclear Medicine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Nuclear Medicine Typical Downstream Customers
- 8.5 Nuclear Medicine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
